206 related articles for article (PubMed ID: 37642024)
1. Risk of Incident Venous Thromboembolism Among Patients With Bullous Pemphigoid or Pemphigus Vulgaris: A Nationwide Cohort Study With Meta-Analysis.
Chen TL; Huang WT; Loh CH; Huang HK; Chi CC
J Am Heart Assoc; 2023 Sep; 12(17):e029740. PubMed ID: 37642024
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
3. Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
Chen CL; Wu CY; Lyu YS; Chou YJ; Chang YT; Wu CY
J Dermatol; 2022 Aug; 49(8):753-761. PubMed ID: 35491650
[TBL] [Abstract][Full Text] [Related]
4. Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population-based cohort study.
Tang CH; Sue YM; Chang CL; Wang CC
J Dermatol; 2023 Dec; 50(12):1568-1575. PubMed ID: 37665203
[TBL] [Abstract][Full Text] [Related]
5. Venous Thromboembolism in Patients With Bullous Pemphigoid.
Schneeweiss MC; Merola JF; Wyss R; Silverberg JI; Mostaghimi A
JAMA Dermatol; 2023 Jul; 159(7):750-756. PubMed ID: 37285147
[TBL] [Abstract][Full Text] [Related]
6. The incidence of herpes zoster in cutaneous lupus erythematosus (CLE), dermatomyositis (DM), pemphigus vulgaris (PV), and bullous pemphigoid (BP).
Robinson ES; Payne AS; Pappas-Taffer L; Feng R; Werth VP
J Am Acad Dermatol; 2016 Jul; 75(1):42-8. PubMed ID: 27317514
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
Ungprasert P; Wijarnpreecha K; Thongprayoon C
Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440
[TBL] [Abstract][Full Text] [Related]
8. Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
Rosi-Schumacher M; Baker J; Waris J; Seiffert-Sinha K; Sinha AA
Front Immunol; 2023; 14():1159351. PubMed ID: 37180132
[TBL] [Abstract][Full Text] [Related]
9. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
10. A five year retrospective study on pemphigus and pemphigoid.
Kyriakis K; Tosca A; Lehou J; Hatzis J; Vareltzidis A; Stratigos J
Australas J Dermatol; 1989; 30(1):33-6. PubMed ID: 2486050
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoid.
Han Z; Fan Y; Wu Q; Guo F; Li S; Hu X; Zuo YG
Int Immunopharmacol; 2024 Feb; 128():111470. PubMed ID: 38185033
[TBL] [Abstract][Full Text] [Related]
12. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease: A Systematic Review and Meta-analysis.
Chen TL; Lee LL; Huang HK; Wang JH; Chen LY; Tsai HR; Loh CH; Chi CC
JAMA Dermatol; 2022 Jan; 158(1):59-67. PubMed ID: 34851364
[TBL] [Abstract][Full Text] [Related]
13. Risk of Venous Thromboembolism Among Adults With Atopic Dermatitis.
Chen TL; Huang WT; Loh CH; Huang HK; Chi CC
JAMA Dermatol; 2023 Jul; 159(7):720-727. PubMed ID: 37256633
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in patients with pemphigus: A cohort study.
Leshem YA; Atzmony L; Dudkiewicz I; Hodak E; Mimouni D
J Am Acad Dermatol; 2017 Aug; 77(2):256-260. PubMed ID: 28495498
[TBL] [Abstract][Full Text] [Related]
16. Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris.
Ergun EZ; Aoki R; Horváth ON; Hartmann D; Satoh TK; Calabrese L; Aksu AEK; Gürel MS; Manav V; Flaig MJ; Sárdy M; Ruzicka T; French LE; Bağcı IS
Exp Dermatol; 2023 Sep; 32(9):1412-1419. PubMed ID: 37260420
[TBL] [Abstract][Full Text] [Related]
17. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.
Langan SM; Smeeth L; Hubbard R; Fleming KM; Smith CJ; West J
BMJ; 2008 Jul; 337(7662):a180. PubMed ID: 18614511
[TBL] [Abstract][Full Text] [Related]
18. Single-cell sequencing reveals distinct immune cell features in cutaneous lesions of pemphigus vulgaris and bullous pemphigoid.
Hu Z; Zheng M; Guo Z; Zhou W; Zhou W; Yao N; Zhang G; Lu Q; Zhao M
Clin Immunol; 2024 Jun; 263():110219. PubMed ID: 38631594
[TBL] [Abstract][Full Text] [Related]
19. The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study.
Kridin K; Schonmann Y; Weinstein O; Schmidt E; Ludwig RJ; Cohen AD
J Am Acad Dermatol; 2021 Jul; 85(1):79-87. PubMed ID: 33744354
[TBL] [Abstract][Full Text] [Related]
20. Immune cells in pemphigus vulgaris and bullous Pemphigoid: From pathogenic roles to targeting therapies.
Yuan Q; Yang W; Zhang X
Int Immunopharmacol; 2023 Oct; 123():110694. PubMed ID: 37523970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
